Placebo News and Research

RSS

Study reports presence of structural changes in the brain during medication treatment for depression

A study led by Ravi Bansal, PhD, and Bradley S. Peterson, MD, of The Saban Research Institute of Children's Hospital Los Angeles, has found structural differences in the cerebral cortex of patients with depression and that these differences normalize with appropriate medication.

7 Mar 2017

Vaginal progesterone decreases preterm birth, infant mortality in twin gestations with short cervix

Treatment with vaginal progesterone reduced the risk of preterm birth, neonatal complications and death in pregnant women with twins and who have a short cervix— a risk factor for preterm birth— according to a meta-analysis of individual patient data by researchers at the National Institutes of Health, the Wayne State University School of Medicine, the Detroit Medical Center, and other institutions in the United States and abroad.

7 Mar 2017

Concentrated blueberry supplement increases cognitive function in older adults, study finds

Drinking concentrated blueberry juice improves brain function in older people, according to research by the University of Exeter.

7 Mar 2017

Study finds link between extended use MAO-B inhibitors and slow clinical decline in PD patients

There has long been interest in whether monoamine oxidase type B (MAO-B) inhibitors slow progression of Parkinson's disease (PD) and improve long-term outcomes.

6 Mar 2017

Study shows and measures effects of cognitive-enhancing drugs on chess play

The first study to both show and measure the effects of cognitive-enhancing drugs such as modafinil, methylphenidate, and caffeine, on chess play is being published in the March edition of the peer-reviewed journal European Neuropsychopharmacology.

6 Mar 2017

FDA approves new nasal spray for adults who overproduce urine at night

The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria (overproduction of urine during the night).

3 Mar 2017

Neurofeedback shows promise in reducing symptoms of CIPN in cancer survivors

A type of functional brain training known as neurofeedback shows promise in reducing symptoms of chemotherapy-induced nerve damage, or neuropathy, in cancer survivors, according to a study by researchers at The University of Texas MD Anderson Cancer Center.

3 Mar 2017

Study finds link between vitamin D levels and severity of malabsorption issues

Natural health experts BetterYou have welcomed a recommendation by leading gastroenterology expert Isobel Mason, to take a vitamin D supplement to reduce Crohn’s flare-ups.

From BetterYou Ltd 3 Mar 2017

Asking three questions could help identify most appropriate treatment for depression, study suggests

The probability that people suffering from depression will complete treatment can be increased significantly by asking them three questions before beginning therapy, according to a new study undertaken at the University of Haifa.

3 Mar 2017

Clarkson University researcher explores acute effects of cocoa and caffeine

Deep down, we always knew it, but science is proving that cocoa and caffeine are indeed the best marriage ever. Clarkson University researcher Ali Boolani recently completed a study that explores the powers of these two dark delights.

3 Mar 2017

First-ever clinical study shows that older adults benefit from hearing aid use

The first-ever placebo-controlled, double-blind, randomized clinical trial of hearing aid outcomes published today in the American Journal of Audiology shows that older adults benefit from hearing aid use.

2 Mar 2017

Treating pregnant women for mild thyroid dysfunction provides no benefit, study finds

A large national study suggests that treating pregnant women for mildly low thyroid function does not improve the IQs of their babies or reduce preterm births or other negative outcomes.

2 Mar 2017

New wireless patch may help reduce migraine pain as well as drugs, study suggests

A preliminary study suggests that a new, wireless patch that you wear on your arm may help reduce migraine pain as well as drugs. The study is published in the March 1, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.

2 Mar 2017

Probiotic combination may help reduce hay fever symptoms, research shows

As we head into allergy season, you may feel less likely to grab a hanky and sneeze. That's because new University of Florida Institute of Food and Agricultural Sciences research shows a probiotic combination might help reduce hay fever symptoms, if it's taken during allergy season.

2 Mar 2017

Study finds new drug treatment to be safe and well-tolerated in pediatric patients with anxiety

A pilot study of guanfacine, a controlled-release alpha2-agonist, in children and adolescents with general, separation-related, and social anxiety disorder showed the drug to be safe and well-tolerated and provided preliminary evidence of its potential effectiveness.

1 Mar 2017

Study findings may bring new hope for children and teens with epilepsy

There's good news for kids with epilepsy. While several new drugs have come out in the last several years for adults with epilepsy, making those drugs available for children and teenagers has been delayed due to the challenges of testing new drugs on children.

28 Feb 2017

GUMC launches phase II clinical study to examine safety of cancer drug for Parkinson's disease

Georgetown University Medical Center today announces the launch of a phase II clinical trial to study the safety of the cancer drug nilotinib and its effects on clinical outcomes and biomarkers in people with Parkinson's disease.

27 Feb 2017

Deep brain stimulation may help improve mental, physical health in patients with anorexia nervosa

Deep brain stimulation might alter the brain circuits that drive anorexia nervosa symptoms and help improve patients’ mental and physical health, according to a small study published in The Lancet Psychiatry.

25 Feb 2017

Alzheimer's drug prescribed off-label could accelerate cognitive decline for some patients

Donepezil, a medication that is approved to treat people with Alzheimer's disease, should not be prescribed for people with mild cognitive impairment without a genetic test.

24 Feb 2017

Novel antiviral drug can protect transplant patients against CMV infections

In a significant advance in improving the safety of donor stem cell transplants, a major clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women's Hospital has shown that a novel agent can protect against the most common viral infection that patients face after transplantation.

24 Feb 2017

Placebo News and Research

Study reports presence of structural changes in the brain during medication treatment for depression

Vaginal progesterone decreases preterm birth, infant mortality in twin gestations with short cervix

Concentrated blueberry supplement increases cognitive function in older adults, study finds

Study finds link between extended use MAO-B inhibitors and slow clinical decline in PD patients

Study shows and measures effects of cognitive-enhancing drugs on chess play

FDA approves new nasal spray for adults who overproduce urine at night

Neurofeedback shows promise in reducing symptoms of CIPN in cancer survivors

Study finds link between vitamin D levels and severity of malabsorption issues

Asking three questions could help identify most appropriate treatment for depression, study suggests

Clarkson University researcher explores acute effects of cocoa and caffeine

First-ever clinical study shows that older adults benefit from hearing aid use

Treating pregnant women for mild thyroid dysfunction provides no benefit, study finds

New wireless patch may help reduce migraine pain as well as drugs, study suggests

Probiotic combination may help reduce hay fever symptoms, research shows

Study finds new drug treatment to be safe and well-tolerated in pediatric patients with anxiety

Study findings may bring new hope for children and teens with epilepsy

GUMC launches phase II clinical study to examine safety of cancer drug for Parkinson's disease

Deep brain stimulation may help improve mental, physical health in patients with anorexia nervosa

Alzheimer's drug prescribed off-label could accelerate cognitive decline for some patients

Novel antiviral drug can protect transplant patients against CMV infections

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News